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1. Introduction 
Coronary artery disease remains the principal cause of death in developed countries, with 
acute coronary syndrome (ACS) contributing greatly to cardiovascular morbidity and 
mortality. Optimal revascularization therapy in these patients is of major importance and 
remains the basis for favorable outcomes. The intervention-based strategy plays a major role 
in the management of acute-phase patients because of the cardiovascular benefits 
demonstrated in numerous studies. In serious cases, ACS can be encountered with life 
threatening episodes such as cardiogenic shock or cardiac arrest in the peri-intervention 
period. Compared with the intra-aortic balloon pump (IABP), percutaneous 
cardiopulmonary support (PCPS) can maintain hemodynamic stability in the abscence of an 
intrinsic cardiac rhythm or effective cardiac output and can provide excellent mechanical 
circulatory support in these urgent or emergent situations because it can be implanted and 
stabilized promptly in many different hospital locations, including the cardiac 
catheterization laboratory, and if necessary, in the emergency room or intensive care unit. 
Some reports use PCPS to rescue ACS patients with cardiopulmonary failure (Sung, 2006; 
Grambow, 1994). Herein, we present our experience with the use of PCPS for initial 
stabilization in patients with unstable hemodynamics before or after coronary intervention 
and discuss some of the pertinent issues related to this topic. 
2. Extracorporeal membrane oxygenation 
2.1 Introduction 
Extra corporeal membrane oxygenation (ECMO) techniques became available40 years 
ago. In 1972, the first veno-arterial ECMO system for humans was used in a patient with 
acute respiratory distress syndrome (Hill, 1972). The first successful application of 
neonatal ECMO was performed by Bartlett in 1976 (Bartlett, 1976), and the concept of 
veno-venous ECMO to eliminate CO2 was established by Kolobow in 1980 (Kolobow, 
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1980). In the last decade, enormous advances have been made and ECMO has become 
more reliable with improved equipment and increased experience, which is reflected in 
the improved results. ECMO is used for the management of life threatening pulmonary or 
cardiac failure (or both), when no other form of treatment has been or is likely to be 
successful. ECMO is generally used as temporary support while awaiting recovery of 
organs.  
ECMO is essentially a modification of the cardiopulmonary bypass circuit, which is used 
routinely in cardiac surgery. Blood is drained from the venous system peripherally or 
centrally, oxygenated with carbon dioxide extracted, then returned back to the arterial 
system peripherally or centrally.  
Although ECMO remains a short-term support device, the use of such a circuit for extended 
periods (days to weeks) has required some modifications. Specially, the circuit is smaller 
than a standard cardiopulmonary bypass circuit, transportable, and closed to the 
atmosphere. The cannulae are also specifically designed for ECMO. The duration of support 
with ECMO has greatly increased with improving oxygenators and medical management, 
and whereas support was previously on the order of days, patients can now be maintained 
on ECMO for weeks. In most patients the duration of support required is approximately 1 
week. Most commonly, ECMO is used in an emergency or urgent situation after failure of 
other treatment modalities.  
2.2 Indications for ECMO 
ECMO is indicated for all the reversible pulmonary or cardiac failures (or both) refractory to 
conventional therapy. ECMO is usually used for initial stabilization and temporary support 
while awaiting recovery of organs. However, physicians should keep in mind that the 
results of ECMO support are consistently related to the indication for institution of such 
therapy. 
With respect to cardiac failure, ECMO has been used successfully to resuscitate patients 
with cardiac arrest or cardiogenic shock due to acute coronary syndrome, post-cardiotomy 
cardiac failure, transplant rejection, intractable dysrhythmia, ruptured coronary artery graft, 
pericardial tamponade, cardiac trauma, sepsis, and myocarditis. ECMO has also been 
effective in patients with secondary cardiac failure due to respiratory insufficiency, 
hypothermic arrest from cold-water submersion, and drug overdose. The indications for 
ECMO in cardiopulmonary resuscitation are summarized in Table 1. 
In making the decision to use ECMO, several considerations must be weighed. Most 
importantly, physicians must consider the possibility of cardiac recovery. If recovery is not 
expected, consideration must be given to patient eligibility for heart transplantation, other 
mechanical assist devices to bridge the patient to transplantation, or a definitive mechanical 
assist device to be inserted as destination therapy. Moreover, patient selection is the most 
important prognostic indicator. Although some relative contraindications have been 
proposed, there are few generally accepted absolute contraindications to ECMO. 
Unwitnessed cardiac arrest, aortic dissection, and terminal illness are considered to be the 
most important contraindications. The mortality rate after an unwitnessed cardiac arrest 
approaches 100% and has not changed with the use of ECMO. Early and effective 
resuscitation can allow for neurologically-intact survivors, but this is less likely to occur in 
an unwitnessed arrest. Aortic insufficiency is another relative contraindication, particularly 
if severe. In such situations, aortic valve replacement should be considered. Lesser degrees 
of aortic insufficiency may be managed with a left ventricular vent. Failure to insert a vent 
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leads to ventricular distension, compromised subendocardial blood flow with an impact on 
recovery, and the ability to wean from ECMO.  
Renal failure, hepatic failure, and significant neurologic disease are relative 
contraindications to ECMO, depending on the existence of other therapeutic options and the 
degree of dysfunction (Meurs, 2005).  
 With respect to respiratory failure, the most common indication is due to adult respiratory 
distress syndrome (ARDS), pneumonia, trauma, or primary graft failure following lung 
transplantation. ECMO is also used for neonatal and pediatric respiratory support. The use 
of ECMO in premature neonates is the mainstay of treatment for immature lungs and 
insufficient surfactant. 
 More recently, indications for ECMO have been expanded to pro-procedural supports, such 
as major airway intervention/surgery and cardiac intervention, including high-risk 
coronary angioplasty or arrhythmia ablation (Table 1). In a small and retrospective study, 
Grambow et al. proposed that patients requiring coronary revascularization by angioplasty 
who have severe left ventricular dysfunction or target vessels supplying greater than 50% of 
the myocardium are candidates for elective ECMO (Grambow, 1994). 
 
Indications 
Resuscitation 
    Cardiac arrest 
    Cardiogenic shock 
    Cardiac trauma 
    Respiratory insufficiency 
    Status asthmaticus 
    Smoke inhalation 
    Drug overdose 
    Pulmonary edema 
    Massive pulmonary embolism 
    Hypothermia 
Procedural support 
    Angioplasty 
    Arrhythmia ablation 
    Pulmonary embolectomy 
    Coronary artery bypass grafting 
    Cerebral arteriovenous malformation resection 
    Donor heart preservation 
    Abdominal aortic graft replacement 
    Tracheal reconstruction 
    Ventricular assist device placement 
Table 1. Indications for ECMO 
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2.3 Mode of ECMO 
ECMO can be inserted in a veno-venous (VV) mode, which provides oxygenation and CO2 
removal, and thus is used for pulmonary failure not responding to mechanical ventilation, 
or can be used in a veno-arterial (VA) mode providing sufficient end-organ perfusion and 
gas exchange. VA ECMO can be instituted peripherally or centrally.  
VV ECMO refers to blood being drained from the venous system and returned to the 
venous system. This mode only provides respiratory support and is achieved by peripheral 
cannulation, usually via the femoral or jugular veins. VA ECMO refers to blood being 
drained from the venous system and returned to the arterial system. The VA ECMO mode 
provides cardiac and respiratory support, and can be divided into two groups according to 
vascular access peripherally or centrally.  
When using ‘central’ cannulation, in which the ascending aorta and right atrium are directly 
cannulated, this is referred to as ‘central’ ECMO. Central ECMO allows better flow because 
of better drainage from the right atrium with a bigger cannula and is usually required in 
patients with a larger body surface area (> 2.0 m2). The other advantage of central ECMO is 
that the flow directly from the outflow cannula into the aorta provides antegrade flow to the 
arch vessels, coronary arteries, and the rest of the body (Fig. 1). However, central ECMO 
also has its drawbacks. Insertion of central ECMO requires a median sternotomy to allow 
the cannulation. This is a time-consuming procedure and increases the risk of bleeding from 
the sternum and also of infection. In contrast to central ECMO, it can be achieved by 
peripheral vascular access and is called ‘peripheral’ ECMO or percutaneous 
cardiopulmonary support (PCPS), in which insertion is more prompt via a bed-side 
procedure than central ECMO because there is no need for a sternotomy and the risk of   
 
 
 
 
Fig. 1. Mode of ECMO. Panel A represents central ECMO and panel B represents peripheral 
ECMO. 
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bleeding is decreased. However, the retrograde aortic flow provided by peripheral ECMO 
from the femoral artery leads to admixing in the arch (two circulation syndrome). For this 
reason, monitoring of oxygenation from a right radial arterial line would be prudent. 
Mechanical ventilation must be continued during ECMO support to maintain oxygen 
saturation of blood ejected from the left ventricle to at least above 90%. In patients on PCPS, 
single access cannulae may not be sufficient to achieve satisfactory perfusion and gas 
exchange. In these patients a second access cannula is inserted via the right internal jugular 
vein ,so sufficient flow can be achieved. 
2.4 Maintenance and Weaning of ECMO 
The basic function of VA ECMO in supplying mechanical circulatory support is to drain 
blood from the venous circulation, oxygenate the blood, and then return the blood to the 
arterial circulation at physiologic perfusion pressures. Although ECMO efficiently unload 
the right ventricle, ECMO is not efficient in unloading the left ventricle. Indeed, ECMO 
increases left ventricular afterload, thus negatively affecting myocardial recovery, even 
though left ventricular preload is significantly reduced by the diminished return from the 
lungs. For this reason, attempts to improve left ventricular contractility, reducing left 
ventricular distension, left ventricular afterload, and clot formation are of utmost 
importance. Such measures should include inotropic support and may include intra-aortic 
balloon pumping (IABP), which can decrease left ventricular afterload and therefore 
reducing wall stress, especially during the critical initial period. Other options include 
inserting a left ventricular vent to empty the ventricle connecting this line into the venous 
line of the ECMO circuit, to place an additional drainage catheter in the left atrium that can 
be placed via the percutaneous route (Aiyagari, 2006), or to perform an atrial septostomy to 
decompress the left heart (Koenig, 1993).  
ECMO flow can be volume-dependent and will drop with hypovolemia, cannula 
malposition, pneumothorax, and pericardial tamponade, and usually manifests as ‘kicking’ 
or ‘chatter’ of the venous tubing as well as a drop in output. Management includes a volume 
challenge, and exclusion of intra-abdominal distension or compartment syndrome, cardiac 
tamponade, or pneumothorax. If a volume challenge does not work, a slight reduction in 
flow may be helpful or there may be a need to insert another venous cannula. Further, 
centrifugal pumps in contrast to roller pumps are afterload-dependent, and therefore 
hypertension is another variable that can reduce flow and should be avoided. 
From a respiratory point of view, hypoxia is treated by increasing the flow rate and FiO2 of 
the ECMO circuit, not by altering the FiO2 and PEEP on the ventilator. Attempts to support 
and rest the lung should be made to wean the FiO2 on the ventilator and maintain a PEEP 
level of 8-15 cmH2O. A protective lung ventilation strategy with low plateau pressures and 
low tidal volumes should be attempted as well as low respiratory rates, unless attempting to 
wean off the ECMO circuit. PCO2 control should be via the ECMO fresh gas flow to the 
oxygenator, not by altering the respiratory rate on the ventilator. 
From a cardiac point of view, the aim should be to minimize the use of inotropes, and thus 
rest the heart. However, a low-dose inotrope infusion is often maintained to ensure some 
contractility and adequate emptying of the left ventricle. It is also important to ensure the 
patient is not hypovolemic.  
There are no standardized methods or techniques by which to wean from ECMO. With 
respect to VV ECMO, weaning and discontinuation are considered when there is evidence 
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of substantial improvement in the underlying disease process and cardiopulmonary 
function based on radiographs, laboratory parameters, hemodynamic parameters, and gas 
exchange. While monitoring these parameters, flow through the circuit can gradually be 
reduced. When a reduction in flow of 75% can be achieved without changes in 
cardiopulmonary status, membrane gas flow can be stopped. If the patient tolerates those 
challenges for 12 hours with adequate gas exchange and hemodynamic parameters, VV 
ECMO can be removed (Gravlee, 2008).  
With respect to VA ECMO, weaning and discontinuation are considered when there is 
evidence of cardiac recovery, including increased blood pressure, return of pulsatility or 
increased pulsatility on the arterial pressure waveform, and falling central venous and/or 
pulmonary pressures. Weaning is performed under echocardiographic guidance with 
regular arterial blood gas and lactate measurements. ECMO flow rates are slowly weaned, 
while inotropes and ventilator support are adjusted after echocardiography confirms 
adequate ventricular filling and ejection. Blood gases and serum lactate levels are then 
assayed to confirm adequate gas exchange and oxygen delivery, respectively. Until a 
reduction in flow of 75% can be achieved or a flow rate is below 1 – 1.5 liter/min without 
changes in cardiopulmonary status over 12 – 24 hours, weaning can proceed. If the patient 
tolerates those challenges for 12 hours with adequate parameters, VA ECMO can be 
removed. 
2.5 Complications of ECMO 
Bleeding and hemolysis, multi-organ failure, infection, and equipment failure are the 
common complications that contribute to morbidity and mortality associated with ECMO in 
adults. The complications that have been reported to the Extracorporeal Life Support 
Organization (ELSO) Registry in adult patients treated with ECMO are listed in Table 2, and 
data on complications and events reported in the ELSO Registry are shown in Table 3 
(Meurs, 2005).  
The most common complication associated with the use of ECMO is bleeding from 
cannulation sites, with typical rates ranging 4-14% (Kurusz, 2002). Excessive bleeding is 
caused by multiple factors. Hepatic congestion and failure, malnutrition, multiple 
cannulation sites, low-dose anticoagulation with heparin, decreased platelet function, 
activation of the coagulation cascade secondary to hemolysis, and hyperfibrinolysis from 
contact with prosthetic surfaces all may contribute to increased bleeding. The use of 
heparin-coated circuits in addition to the antifibrolytics and vitamin K therapies has 
contributed to lower bleeding rates. Vena cava tears or rupture with retroperitoneal 
bleeding, and arterial or aortic injury including dissection and perforation that required 
surgical exploration and reconstruction have occurred. Other non-cannula-related bleeding 
complications include pulmonary and gastrointestinal hemorrhage.  
Ischemic injury to the brain, kidneys, liver, and other end organs has been attributed to 
prolonged resuscitation and as well as inadequate pump flow. Recovery from a moderate 
hypoxic-ischemic insult is possible for most organs; however, neurologic recovery is 
frequently limited. Emergency ECMO and early coronary perfusion using percutaneous 
transluminal coronary angioplasty (PTCA) can result in good myocardial recovery. By using 
mild hypothermia in conjunction with ECMO during PTCA, a 2- to 5-fold increase in the rate 
of good neurologic recovery was achieved in a series reported by Nagao et al (Nagao, 2000). 
Overall infection rates in temporary mechanical circulatory support have been reported to 
be as high as 30-40% (Patel, 2003). Immobilization, poor nutritional status, and indwelling 
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catheters and tubes are all likely to contribute to the high incidence of infection. Although 
infrequent now, severe lower limb ischemia leading to amputation has occurred with 
femoral artery cannulation. Perfusion in the cannulated leg should be monitored closely for 
evidence of ischemia. Placement of a smaller, additional femoral artery cannula to perfuse 
the lower limb distal to the ECMO cannula has reduced the risk of this complication. Limb 
complications have been reported to occur in as many as 25% of patients prior to the use of 
the distal cannulation technique (Patel, 2003; Schwarz, 2003). 
 
Complications
Cannula related
   Perforated femoral or iliac artery
   Retroperitoneal bleed
   Aortic dissection
   Limb ischemia
   Poor venous drainage
   Failure to cannulate
Hemorrhagic
   Bleeding at cannulation site
   Bleeding at surgical site
   Pulmonary hemorrhage
   Gastrointestinal hemorrhage
   Cerebrovascular accident
Thromboembolic
   Limb ischemia
   Pulmonary infarction
   Cerebrovascular accident
Insufficient perfusion
   Ischemic brain injury
   Renal failure
   Hepatic failure
   Multi-systemic organ dysfunction
Technical
   Equipment failure
   Hemolysis
Infection
Insufficient ventricular unloading
   Ventricular dysfunction and pulmonary edema
 
Table 2. Complications associated with ECMO 
www.intechopen.com
 
Coronary Angiography – The Need for Improvement in Medical and Interventional Therapy  
 
138 
Complications Pediatric Adult 
n % n % 
Mechanical     
    Air in circuit 21 3.5 4 2.2 
    Cannula problems 68 11.5 13 7.2 
    Clots: Bladder 31 5.1   
          Bridge 19 3.2 2 1.1 
          Hemofilter 28 4.6 7 3.9 
          Oxygenator 60 10 13 7.2 
          Other 50 8.3 10 5.5 
    Cracks in pigtail connectors 5 0.8 5 2.8 
    Heat exchanger malfunction 1 0.2   
    Other tubing rupture 4 0.7 2 1.1 
    Oxygenator failure 52 8.6 39 21.6 
    Pump malfunction 6 1 1 0.6 
    Raceway rupture 3 0.5   
Metabolic     
    Glucose < 40 mg/dl 14 2.3 1 0.6 
    Glucose > 240 mg/dl 83 13.8 75 41.4 
    Hyperbilirubinemia (> 2 direct or > 15 total) 30 5 14 7.7 
    pH < 7.20 77 12.8 41 22.7 
    pH > 7.60 25 4.2 14 7.7 
Neurologic     
    Brain death clinically determined 70 11.6 27 14.9 
    CNS hemorrhage by US/CT 42 7 1 0.6 
    CNS infarction by US/CT 43 7.1 24 13.3 
Seizures     
    Clinically determined 69 11.4 7 3.9 
    EEG determined 32 5.3 1 0.6 
Pulmonary     
    Pneumothorax requiring treatment 15 2.5 7 3.9 
    Pulmonary hemorrhage 55 9.1 11 6.1 
Renal     
    CAVHD required 41 6.8 39 21.6 
    Hemofiltration required 170 28.2 22 12.1 
Cardiovascular     
    Cardiac arrhythmia 110 17.3 44 24.3 
    CPR required 48 8 12 6.6 
    Hypertension requiring vasodilators 74 12.3 13 7.2 
    Inotropes on ECMO 414 68.7 152 84 
    Myocardial stun by echocardiography 38 6.3 4 2.2 
    PDA: Bidirectional 2 0.3   
          L->R 2 0.3   
          R->L 2 0.3   
    Tamponade: Blood 35 5.8 21 11.6 
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Complications Pediatric Adult 
n % n % 
                Serous 2 0.3   
Hemorrhagic     
    Cannulation site bleeding 105 17.4 40 22.1 
    Disseminated intravascular coagulation 37 6.1 5 2.8 
    GI hemorrhage 19 3.2 7 3.9 
    Hemolysis ( Hemoglobin > 50 mg/dl ) 75 12.4 28 15.5 
    Surgical site bleeding 101 16.8 53 29.3 
Infections     
    Culture-proven infection 54 9 28 15.5 
    White blood cell > 1,500 6 1   
CAVHD = continuous arteriovenous hemodialysis, CNS = central nervous system, CPR = 
cardiopulmonary resuscitation, CT = computed tomography, EEG = electroencephalogram, GI = 
gastrointestinal, L->R = left to right shunt, R->L = right to left shunt, US = ultrasound. 
Table 3. Complications reported to the ELSO Registry (1994 – July 2005) 
In addition, intracardiac thrombus may form within a poorly contracting, nonejecting left 
ventricle or atrium because little blood reaches the left atrium with good right atrial 
drainage (Cohn, 2008). Because intracardiac thrombus may induce systemic embolism, thus 
serial echocardiogram should be followed up for early detection and ECMO patients do 
require low level heparinization to prevent this complication. 
2.6 Outcomes of ECMO 
The results of ECMO support are consistently related to the indication for institution of such 
therapy.  
With respect to VV ECMO, Bartlett et al at the University of Michigan were reviewed in 
1995 and reported that VV ECMO for respiratory failure provided survival to discharge in 
88% of 586 cases of respiratory failure in neonates, 70% for 132 cases of respiratory failure in 
children and 56% for 146 cases of respiratory failure in adults (Bartlett, 1997). In 2008, the 
ELSO revealed similar results; specially 972 cases of ECMO support for respiratory failure 
were reported, of which 53% survived to discharge in the adult population (>18 years). 
Unfortunately, good quality randomized controlled trials of ECMO outcomes in the adult 
population are lacking. The incomplete CESAR (Conventional Ventilation or ECMO for 
Severe Adult Respiratory Failure) was a national randomized controlled trial in the United 
Kingdom funded by the National Health Service and the Health Technology Assessment 
Agency; preliminary results were recently released at the 37th Society of Critical Care 
Medicine Congress in Honolulu in February 2008. The hypothesis was that ECMO will 
improve survival without severe disability by 6 months post-randomization for patients 
with severe, but potentially reversible respiratory failure. Severe disability was defined as 
confined to bed and unable to dress or wash oneself. Suitable patients can be entered from 
any of the 96 participating hospitals and were randomized to either transfer to Glenfiele 
hospital for consideration of ECMO or continued conventional management. The 
conventional group underwent standard clinical practice in the UK. Recruitment was 
conducted from July 2001 to August 2006. Of the 90 patients assigned to receive ECMO, 22 
did not receive ECMO, most often because they improved without it. Patient characteristics 
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were well matched between groups. Of the patients randomly assigned to receive ECMO, 57 
of 90 met the primary endpoint of survival or absence of severe disability at 6 months 
compared with 41 of 87 patients in the conventional ventilation group. This translated to a 
relative risk in favor of the ECMO group of 0.69 (95% confidence interval, 0.05–0.97; P = 
0.03). A significant number of patients had failure of more than 3 organs in both groups (28 
in the ECMO group and 27 in the conventional group). The benefit of ECMO was evident, 
regardless of age, duration of high-pressure ventilation, primary diagnosis at trial entry, and 
number of organs failing (Peek, 2006; Hitt, 2008). 
With respect to VA ECMO, Bartlett et al at the University of Michigan were reviewed in 
1995. Their experience with cardiac failure is somewhat smaller with a 33% survival rate in 
31 adult patients and 48% survival in 105 pediatric patients (Bartlett, 1997). In 2008, ELSO 
revealed similar results that 474 patients were supported for cardiac failure of which only 
33% survived to discharge. In addition, numerous studies have reported various results 
according to the disease diagnosis. The data reported to the ELSO registry has shown that 
myocarditis is associated with a better survival than other diagnosis, with almost three-fifths 
being successfully weaned from ECMO. Similarly, Acker reported that twenty seven (73.0%) 
of a group of 37 patients could be weaned from ECMO and 26 patients (70.3%) were 
discharged from the hospital (Acker, 2001). In this subgroup of patients, ECMO may be used 
as a bridge to recovery, bridge, or transplantation. Cardiac arrest and shock are the most 
common indications for ECMO in adults and the benefits of ECMO for cardiac arrest in 
adults were shown recently (Chen, 2008). Early implementation of ECMO can improve the 
survival rate to 30-40%, as described in multiple published series and the ELSO registry 
(Sung, 2006; Meurs, 2005). For acute myocardial infarction, cardiogenic shock is the leading 
cause of death in hospitalized adults. In these patients, ECMO alone has a limited effect on 
outcome, but when combined with emergency coronary revascularization by angioplasty, it 
may improve survival. Also, the concomitant use of an intra-aortic balloon pump with 
ECMO improves survival in patients with cardiogenic shock. The role of ECMO to provide 
post-cardiotomy support with severe cardiopulmonary dysfunction after cardiac surgery is 
well established. Mechanical circulatory support may be required in the post-operative 
period, either due to the inability to separate from cardiopulmonary bypass, or a 
progressive low cardiac output syndrome due to a number of factors, such as ventricular 
dysfunction, pulmonary hypertension, or intractable arrhythmias. The incidence of post-
cardiotomy myocardial failure is 2-6% in adult cardiac surgical patients. Rousou et al. 
reported that 56% of a group of 16 patients survived ongoing post-operative ventricular 
fibrillation or electromechanical dissociation when ECMO was employed (Rousou, 1994). 
Similarly, 77% of a group of 13 patients described by Kawahito et al. successfully weaned off 
ECMO after circulatory collapse from ventricular fibrillation or electromechanical 
dissociation that was refractory to inotropic agents, IABP, and cardiopulmonary 
resuscitation (Kawahito, 1994). ECMO has been utilized in the cardiac catheterization 
laboratory for resuscitation during sudden cardiovascular collapse to provide temporary 
support for interventional procedures. In a small, retrospective study by Grambow et al., 
rapid initiation of ECMO (within 20 minutes) resulted in the rescue of patients in 
cardiogenic shock, but all patients who experienced cardiac arrest died despite ECMO and 
further interventions. Of those in shocks who were initially salvaged with ECMO, 
approximately 50% survived for 24 hours but only 25% to hospital discharge. Mortality after 
24 hours was attributed to sepsis, multi-organ failure, or congestive heart failure (Grambow, 
1994).  
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3. Our experiences and results 
3.1 Study patients 
Between May 2005 and December 2010, 402 ECMOs were implanted at the Samsung 
Medical Center and a retrospective review was performed. Of them, 79 patients were 
treated with PCPS during peri-intervention period for either refractory cardiac arrest or 
cardiogenic shock. Patients were considered to have refractory cardiac arrest only if 
aggressive attempts at resuscitation were unsuccessful in establishing a stable cardiac 
rhythm. Patients were placed on PCPS for cardiogenic shock if hypotension and peripheral 
hypoperfusion persist despite aggressive fluid replacement and inotropic support.  
3.2 Technique of PCPS 
Both femoral areas were draped under sterile conditions if PCPS was indicated. After the 
intravenous injection of 10 mg/kg of heparin, both the femoral artery and femoral vein were 
cannulated percutaneously using the Seldinger technique. In some patients, femoral 
cannulation was completed after an inguinal incision because of difficulties with the 
percutaneous cannulation. If in the cardiac catheterization, fluoroscopy may be used as well 
to facilitate guide-wire and cannulae placement. The PCPS could be inserted into all patients 
for whom it was intended. According to the patient’s size, 14 to 21 Fr percutaneous femoral 
arterial cannulae (DLP; Medtronic Inc, Minneapolis, MN or RMI; Edwards Lifesciences, 
Irvine, CA) and 17 to 28 Fr percutaneous femoral long venous cannulae (DLP; Medtronic 
Inc, or RMI; Edwards Lifesciences) were used. In some patients, distal femoral arterial 
perfusion was performed using a central line catheter (Arrow International, Reading, PA) 
after distal femoral artery puncture to avoid ischemia of the distal lower leg. The PCPS was 
then started using the Capiox emergency bypass system (EBS; Terumo Inc, Tokyo, Japan), 
which comprises a centrifugal pump, a polypropylene hollow fiber membrane oxygenator, 
and a heparin-coated circuit (Fig 2). The most important benefit of this system is its 
autopriming, which requires less than five minutes to prime the circuit before use and does 
not require specially trained personnel. Once the femoral cannulation was established, the 
PCPS system could be run to stabilize the patient. No hypothermia was applied. If possible, 
we tried to maintain the hematocrit above 35%, the platelet count above 100,000 per μl and 
the activated clotting time (ACT) at 150 to 200 seconds to minimize complications of 
bleeding and thromboembolic complications. After weaning the patients from the PCPS, we 
surgically removed the femoral artery and venous cannulae and repaired the cannulation 
sites to avoid ischemic limb complications. 
3.3 Results 
The clinical characteristics of the patients are listed in Table 4. All patients received VA 
PCPS and 44 patients (55.7%) had IABP concomitantly, as shown in the Table 4. The data on 
complications and events are shown in Table 5.  
Forty-seven patients (59.5%) were weaned from the PCPS in both groups. Twenty-two 
patients (48.9%) in the cardiac arrest group could be weaned from the PCPS; the mean 
duration for PCPS in these patients was 63.1 ± 60.1 (range, 1 to 226; median, 52) hours. 
Twenty five patients (73.5%) in cardiogenic shock group were weaned from the PCPS; the 
mean duration for PCPS in these patients was 71.4 ± 66.2 (range, 1 to 306; median, 57) hours. 
Thirty three patients (41.8%) were discharged from the hospital; fifteen patients (33.3%) 
were in the cardiac arrest group and eighteen patients (50.0%) were in the cardiogenic shock  
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Fig. 2. The percutaneous cardiopulmonary support system used at our institution. It consists 
of a pump console, flowmeter, back-up console, and a holder for the centrifugal pump and 
oxygenator module with a drive motor. This system can be transported using a cart or 
clamped onto the bed. The emergency bypass system circuit, which consists of the 
centrifugal pump, oxygenator, and tubing, is sterilely packed. 
www.intechopen.com
Role of Percutaneous Cardiopulmonary Support (PCPS) in Patients  
with Unstable Hemodynamics During the Peri-Coronary-Intervention Period 
 
143 
 Refractory cardiac arrest Cardiogenic shock 
Patients 45 34 
Age (years) 66.6 ± 12.8 65.5 ± 11.7 
Male : Female 35 : 10 26 : 8 
Timing of PCPS insertion   
Before PCI 24 14 
During PCI 10 3 
After PCI 11 17 
Location of PCPS insertion   
    Catheterization room 17 24 
    Intensive care unit 8 10 
    Emergency room 16  
    Ward 4  
Concomitant use of IABP 22 22 
Duration of PCPS (hours) 63.1 ± 60.1 (1 ~ 226) 71.4 ± 66.2 (1 ~ 306) 
Weaning (%) 22 (48.9%) 25 (73.5%) 
Survived to discharge (%) 15 (33.3%) 18 (50.0%) 
 
PCI = percutaneous coronary intervention, PCPS = percutaneous cardiopulmonary support, IABP = 
intra-aortic balloon pump. 
Table 4. Clinical characteristics 
 
Complications No. 
Limb ischemia 8 
Cannula site bleeding requiring revision 2 
Cardiac tamponade requiring pericardiocentesis 2 
Pulmonary hemorrhage 1 
Hemothorax  1 
Pneumothorax 1 
Hemopneumothorax  1 
 
Table 5. Complications associated with PCPS 
group. There was no statistical difference in weaning from PCPS and survival discharge 
between the groups. 
We divided 79 patients according to the timing of insertion, as follows: group A was 
instituted before coronary intervention; group B was instituted during intervention; and 
group C was instituted after intervention. In group A, 25 (65.8%) of 38 patients were weaned 
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from the PCPS and 18 (47.4%) patients survived to discharge; In group B, 8 (61.5%) of 13 
patients were weaned from the PCPS and all patients survived to discharge; In group C, 14 
(50%) of 28 patients were weaned from the PCPS and 10 (35.7%) patients survived to 
discharge. There was no statistical difference in weaning from PCPS and survival discharge 
between the groups. 
4. Conclusion 
Our results show that PCPS may be a feasible option as a procedural support during 
coronary intervention. Moreover, we suggest that rescue PCPS combined with early 
coronary revascularization by angioplasty may improve survival when acute coronary 
syndrome results in circulatory collapse, and PCPS should be considered in patients with no 
definite contraindications. However, further evaluation and investigation are needed 
because the limitations of the study included the absence of a control group for comparison 
and selection bias.  
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